Berzins T, Axelsson B, Hammarström M L, Hammarström S, Perlmann P
Eur J Immunol. 1984 Dec;14(12):1145-52. doi: 10.1002/eji.1830141216.
Three rabbit antisera (870, 872 and 873) were raised against leucoagglutinin-reactive components from the surface of human T cells. The antibodies reacted with two major glycoproteins of 175 kDa and 105 kDa. None of the antibodies triggered peripheral blood lymphocytes or T cells to proliferation when tested under different culture conditions. All antibodies inhibited the proliferative response to concanavalin A or to allogeneic lymphocytes in mixed lymphocyte culture when whole IgG fractions were used. Complete inhibition of cytotoxic activity was obtained in cell-mediated lympholysis and in natural killer cell cytotoxicity (NK) when fresh peripheral blood lymphocytes were used as effector cells. Weak inhibition was also obtained in NK when mixed lymphocyte culture-activated effector cells were used. The inhibition was stronger, when NK activity was determined against MOLT4 target cells as compared to K562. Whereas F(ab')2 fragments of 873 IgG inhibited cytotoxic T lymphocyte activity completely, Fab fragments of 873 IgG neither inhibited proliferation nor cytotoxic T lymphocyte activity, but gave some inhibition of NK against MOLT4 targets. The results indicate that antibodies against these leucoagglutinin-reactive structures reacted with polypeptides similar to or identical with the human "leukocyte function-associated antigen-1" (LFA-1) considered to be an important mediator of cell-cell interactions and nonspecific adherence.
制备了三种兔抗血清(870、872和873),它们针对人T细胞表面的白细胞凝集素反应性成分。这些抗体与175 kDa和105 kDa的两种主要糖蛋白发生反应。在不同培养条件下进行测试时,没有一种抗体能促使外周血淋巴细胞或T细胞增殖。当使用完整的IgG组分时,所有抗体在混合淋巴细胞培养中均抑制对刀豆球蛋白A或对同种异体淋巴细胞的增殖反应。当使用新鲜外周血淋巴细胞作为效应细胞时,在细胞介导的淋巴细胞溶解和自然杀伤细胞细胞毒性(NK)中均获得了细胞毒性活性的完全抑制。当使用混合淋巴细胞培养激活的效应细胞时,在NK中也获得了微弱的抑制。与K562相比,当针对MOLT4靶细胞测定NK活性时,抑制作用更强。虽然873 IgG的F(ab')2片段完全抑制细胞毒性T淋巴细胞活性,但873 IgG的Fab片段既不抑制增殖也不抑制细胞毒性T淋巴细胞活性,但对针对MOLT4靶标的NK有一定抑制作用。结果表明,针对这些白细胞凝集素反应性结构的抗体与类似于或等同于被认为是细胞间相互作用和非特异性黏附的重要介质的人“白细胞功能相关抗原-1”(LFA-1)的多肽发生反应。